×

Get the Prostate Cancer Patient Guide, available as a free emailed pdf.

Go here to learn more or to get a mailed copy.

My Prostate Cancer Story: Brian Custer

“Do you want to live or do you want to die?” That’s a question Brian Custer asks men, especially African-American men, when they aren’t sure whether to get checked for prostate cancer. Read More

10/13/2016

My Prostate Cancer Story: Muhit Rahman

“It’s always life-altering to hear that you have cancer. Until you get that news, you don’t have cancer. And then all of a sudden, you do.” Read More

New Clinical Trial Methods Accelerate Research and Development

Prostate cancer can be slow to progress, frustrating the development of new therapies for patients with early, high-risk disease. New results from ICECaP (Intermediate Clinical Endpoints for Cancer of the Prostate), a PCF-supported initiative led by Dr. Christopher Sweeney, will cut the time required to assess new therapies for aggressive. Read More

Interview with an Expert: Active Surveillance

Christopher Barbieri, M.D., Ph.D. Assistant Professor, Urology Assistant Professor, Cell and Developmental Biology Weill Cornell Medicine New York Presbyterian Medical Center “There’s no one way to select candidates for active surveillance,” says  urologist and molecular biologist Chris Barbieri, M.D., Ph.D., who treats men with all kinds of prostate cancer and. Read More

Active Surveillance:  What You Need to Know

Is active surveillance right for you?  The answer to this question varies, depending on a bunch of factors: your particular form of prostate cancer, your age and general health, and also on the criteria used to select men for active surveillance programs from hospital to hospital. First, what is active. Read More

A Not-So-Good Practice Proves Harmful in African-American Men

It wasn’t that great of an idea to start with: giving hormonal therapy to lower testosterone in men with localized prostate cancer to make them eligible for radiation seed treatment.  The idea is that a short course of hormonal therapy – usually a shot of Lupron or Zoladex – will. Read More

10/12/2016

For Some Advanced Cancers, What Might be Cures

We may have turned the corner.  We’re not there yet, but wow, are we hopeful!  At the Prostate Cancer Foundation, our goal has always been to put ourselves out of business by curing this terrible disease.  Not just by catching it early, or by curing cancer that’s confined to the. Read More

Genes that Discriminate

“African-American men are discriminated against by prostate cancer, and for the first time, we know why.”  This was oncologist Jonathan Simons, M.D., CEO of the Prostate Cancer Foundation, talking to the Congressional Black Caucus at a special symposium on prostate cancer. Simons was telling the lawmakers about the trailblazing work. Read More

On the Horizon: Understanding Exactly How Prostate Cancer Targets Men of African Ancestry

When it comes to lethal prostate cancer, men of African descent are born with a genetic Achilles heel – or more likely, several points of weakness that make them vulnerable.  It’s not all genetic; the deck is stacked against these men for many reasons, including the high-fat, low-vegetable Western diet,. Read More

Prostate Cancer and African Ancestry

Men of African descent are more likely to develop prostate cancer, and African American men are more than twice as likely caucasian men to die from it. Although lifestyle habits contribute to this greater likelihood, it is chiefly the result of certain genes that men of African descent possess. Learn. Read More